Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Because bremelanotide (PT-141, marketed as Vyleesi) was engineered from Melanotan 2s MC4R activity and did earn FDA approval for hypoactive sexual desire disorder, it is tempting to borrow that legitimacy for Melanotan 2 itself
It worked magic for me
Dosing and Administration PT-141 Dosing The FDA-approved dose is straightforward and fixed: 1.75 mg subcutaneous injection, at least 45 minutes before anticipated sexual activity Maximum one dose per 24-hour period Maximum 8 doses per month Injection sites: abdomen (preferred) or anterior thigh Vyleesi is supplied as a pre-filled single-dose auto-injector requiring no reconstitution
One manufacturer study found their glycolipid also demonstrated sebum reduction and helped reduced oiliness after four weeks
